Archives of General Internal Medicine

Reach Us +1 (202) 780-3397

Mini Review - Archives of General Internal Medicine (2024) Volume 8, Issue 3

Immunodeficiencies: Unraveling the Complexities of Immune System Disorders

Pioto Diedor *

Department of General and Transplantation Surgery, Medical University of Warsaw, Poland

*Corresponding Author:
Pioto Diedor
Department of General and Transplantation Surgery, Medical University of Warsaw, Poland
E-mail: piotodiedor@wp.pl

Received: 30-May-2024, Manuscript No. AAAGIM-24-136834; Editor assigned: 03-Jun-2024, PreQC No. AAAGIM-24-136834 (PQ); Reviewed: 17-Jun-2024, QC No. AAAGIM-24-136834; Revised: 19-Jun-2024, Manuscript No. AAAGIM-24-136834(R); Published: 26-Jun-2024, DOI:10.35841/aaagim-8.3.237

Citation: : Diedor P. Immunodeficiencies: Unraveling the complexities of immune system disorders. Arch Gen Intern Med. 2024;8(3):237.

Visit for more related articles at Archives of General Internal Medicine

Introduction

Immunodeficiencies are a group of disorders characterized by an impaired immune system that is unable to adequately protect the body from infections and diseases. These disorders can be congenital or acquired and vary significantly in their presentation and severity. Understanding the complexities of immunodeficiencies is crucial for diagnosis, treatment, and management. Immunodeficiencies can be broadly categorized into primary (congenital) and secondary (acquired) immunodeficiencies. Primary immunodeficiencies are usually genetic and present at birth. They result from mutations affecting the development and function of the immune system. Over 400 different PIDs have been identified [1, 2].

Severe Combined Immunodeficiency (SCID) often referred to as “bubble boy disease,” SCID is characterized by a severe defect in both T and B lymphocytes, leading to extreme vulnerability to infections. Common Variable Immunodeficiency (CVID) involves a significant reduction in antibody production, leading to recurrent bacterial infections, particularly in the respiratory and gastrointestinal tracts. X-Linked Agammaglobulinemia (XLA) caused by mutations in the BTK gene, XLA results in a lack of mature B cells and a severe reduction in all types of antibodies [3, 4].

Secondary immunodeficiencies are acquired due to external factors such as infections, malnutrition, or medical treatments. HIV attacks and destroys CD4+ T cells, leading to Acquired Immunodeficiency Syndrome (AIDS) if untreated. This severely compromises the immune system, making individuals susceptible to opportunistic infections and certain cancers. Chemotherapy for cancer treatment often damages rapidly dividing cells, including those in the bone marrow, leading to reduced production of white blood cells and impaired immune responses [5, 6].

Deficiency in essential nutrients can impair the immune system. Protein-energy malnutrition and deficiencies in vitamins A, C, D, and E, as well as zinc, are particularly impactful. Immunodeficiencies can manifest in various ways, primarily through increased susceptibility to infections, autoimmunity, and malignancies. Patients with immunodeficiencies frequently suffer from recurrent, severe, or unusual infections. These infections can be bacterial, viral, fungal, or parasitic. For example, individuals with SCID are prone to life-threatening infections from common pathogens. Paradoxically, many immunodeficiencies are associated with an increased risk of autoimmune diseases. For instance, patients with CVID may develop autoimmune conditions such as autoimmune hemolytic anemia or rheumatoid arthritis. Immunodeficient individuals have a higher risk of developing cancers. The impaired immune surveillance fails to eliminate emerging cancer cells effectively. For example, individuals with HIV/AIDS have an increased risk of Kaposi's sarcoma and non-Hodgkin lymphoma [7, 8].

Prophylactic antibiotics, antifungals, and antivirals are often used to prevent infections in immunodeficient patients. Good hygiene practices and avoiding exposure to infectious agents are also crucial. For patients with antibody deficiencies such as CVID and XLA, Regular Infusions Of Immunoglobulin (IVIG or SCIG) can help prevent infections and improve quality of life. HSCT can potentially cure certain primary immunodeficiencies, such as SCID, by reconstituting the immune system with healthy donor stem cells. However, this treatment carries significant risks and requires careful patient selection. Recent advances in gene therapy offer hope for curing genetic immunodeficiencies. Techniques such as CRISPR-Cas9 and viral vector-mediated gene transfer are being explored to correct genetic defects at the molecular level [9, 10].

Conclusion

Immunodeficiencies represent a complex and diverse group of disorders that pose significant challenges to affected individuals and healthcare providers. Advances in diagnostic techniques and treatment options have improved outcomes for many patients. Continued research is essential to unravel the complexities of these disorders and develop more effective therapies.

References

  1. Lin Y, He JJ, Sorensen R,et al. Unraveling neuroHIV in the presence of substance use disorders. J Neuroimmune Pharmacol. 2020;15:578-83.

    2. Indexed at, Google Scholar, Cross Ref

  2. Mertowska P, Smolak K, Mertowski S, et al. Unraveling the Role of Toll-like Receptors in the Immunopathogenesis of Selected Primary and Secondary Immunodeficiencies.  Cells. 2023;12(16): 2055.

    3. Indexed at, Google Scholar, Cross Ref

  3. Gudisa R, Goyal K, Gupta P, et al. Localized and systemic immune response in human reproductive tract. Front Cell Infect Microbiol. 2021;11:649893.

    4. Indexed at, Google Scholar, Cross Ref

  4. Sunila BG, Dhanushkumar T, Dasegowda KR, et al. Unraveling the molecular landscape of Ataxia Telangiectasia: Insights into Neuroinflammation, immune dysfunction, and potential therapeutic target. Neurosci Lett. 2024;828:137764.

    5. Indexed at, Google Scholar, Cross Ref

  5. Cunningham-Rundles C. Common variable immune deficiency: case studies. Blood. 2019; 2019(1): 449-56.

    6. Indexed at, Google Scholar, Cross Ref

  6. Caldirola MS, Martínez MP, Bezrodnik L, et al. Immune monitoring of patients with primary immune regulation disorders unravels higher frequencies of follicular T cells with different profiles that associate with alterations in B cell subsets. Front Immunol. 2020;11:576724.

    7. Indexed at, Google Scholar, Cross Ref

  7. Ghasemian E, Harding-Esch E, Mabey D, et al. When Bacteria and Viruses Collide: A Tale of Chlamydia trachomatis and Sexually Transmitted Viruses. Viruses. 2023;15(9):1954.

    8. Indexed at, Google Scholar, Cross Ref

  8. Jorch SK, McNally A, Berger P, et al. Complex regulation of alarmins S100A8/A9 and secretion via gasdermin D pores exacerbates autoinflammation in familial Mediterranean fever. J Allergy Clin Immunol. 2023;152(1):230-43.

    9. Indexed at, Google Scholar, Cross Ref

  9. Verhaegen AA, Van Gaal LF. Drugs affecting body weight, body fat distribution, and metabolic function—mechanisms and possible therapeutic or preventive measures: an update. Curr Obes Rep. 2021;10:1-3.

    10. Indexed at, Google Scholar, Cross Ref

  10. Calado M, Ferreira R, Pires D, et al. Unravelling the triad of neuroinvasion, neurodissemination, and neuroinflammation of human immunodeficiency virus type 1 in the central nervous system. Rev Med Virol. 2024;34(3):e2534.

    11. Indexed at, Google Scholar, Cross Ref

Get the App